Melanoma Surveillance in the US: Melanoma, Ultraviolet Radiation, and Socioeconomic Status

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this podcast from the Centers for Disease Control and Prevention, Chris Johnson, from the Cancer Data Registry of Idaho, discusses the results of several studies published in a supplement to the November 2011 edition of the Journal of the American Academy of Dermatology that examined the relationship between rates of melanoma and 2 variables recorded at the county level: ultraviolet radiation and socioeconomic status.
 
To listen to the podcast, click here.
Related Articles
Olaparib treats women with advanced ovarian cancer associated with defective BRCA genes.
Priced at approximately $178,000 for 2 courses of treatment, Blincyto will be one of the most expensive cancer medications on the market.
The FDA today approved a new indication for ramucirumab for the treatment of metastatic non-small cell lung cancer.
Merck’s anti–PD-1 therapy Keytruda has demonstrated an overall response rate of 18.5% among patients with PD-L1 positive, advanced triple-negative breast cancer, one of the most aggressive forms of breast cancer.
Latest Issues
$auto_registration$